We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Antipodes Global Investment Company Limited is an asset management business based in Australia. Antipodes Global Investment Company shares (APL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Antipodes Global Investment Company has a trailing 12-month revenue of around $118.3 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.8994 - $1.175 |
|---|---|
| 50-day moving average | $1.1461 |
| 200-day moving average | $1.1195 |
| Target price | N/A |
| PE ratio | 7.2293 |
| Dividend yield | $0.06 (5.29%) |
| Earnings per share (TTM) | $0.157 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1.135
| 1 week (2021-10-13) | 0.44% |
|---|---|
| 1 month (2021-09-20) | -1.30% |
| 3 months (2021-07-20) | 3.18% |
| 6 months (2021-04-20) | -4.54% |
| 1 year (2020-10-20) | 16.41% |
|---|---|
| 2 years (2019-10-18) | 20.74% |
| 3 years (2018-10-19) | 4.61% |
| 5 years (2016-10-20) | 6.07% |
Valuing Antipodes Global Investment Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Antipodes Global Investment Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Antipodes Global Investment Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Antipodes Global Investment Company shares trade at around 7x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $118.3 million |
|---|---|
| Operating margin TTM | 93.47% |
| Gross profit TTM | $118.3 million |
| Return on assets TTM | 11.82% |
| Return on equity TTM | 13.53% |
| Profit margin | 63.51% |
| Book value | 1.209 |
| Market capitalisation | $541.6 million |
TTM: trailing 12 months
Dividend payout ratio: 31.25% of net profits
Recently Antipodes Global Investment Company has paid out, on average, around 31.25% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Antipodes Global Investment Company shareholders could enjoy a 5.29% return on their shares, in the form of dividend payments. In Antipodes Global Investment Company's case, that would currently equate to about A$0.06 per share.
While Antipodes Global Investment Company's payout ratio might seem fairly standard, it's worth remembering that Antipodes Global Investment Company may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 7 September 2021 (the "ex-dividend date").
Over the last 12 months, Antipodes Global Investment Company's shares have ranged in value from as little as $0.8994 up to $1.175. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Antipodes Global Investment Company's is 0.4997. This would suggest that Antipodes Global Investment Company's shares are less volatile than average (for this exchange).
Antipodes Global Investment Company Limited is a listed investment company launched and managed by Antipodes Partners Limited. It invests in the public equity markets across the globe. It benchmarks its performance against the MSCI All Country World Net Index. Antipodes Global Investment Company Limited was formed on October 11, 2016 and is domiciled in Australia.
Shares in the trans-Tasman dairy company are down 55% over the last 12 months.
Shares in the Brisbane-based lender have risen nearly 60% in the last 12 months.
Everything we know about the Tissue Repair IPO, plus information on how to buy in.
This guide will show you step-by-step instructions on how to buy the Illuvium (ILV) token as well as a list of exchanges you can trade it on.
Westpac shares are up 43% over the past 12 months.
Airports, travel agents and pubs are set to soar post lockdown, but should share investors look beyond immediate short-term wins?
Shares in the insurer are up just 10% in the last 12 months.
Everything we know about the Nimy Resources IPO, plus information on how to buy in.
The payment services company’s shares are up 16% in the last year.
Everything we know about the Parabellum Resources IPO, plus information on how to buy in.
